Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
7.75
-0.12 (-1.52%)
At close: May 12, 2025, 4:00 PM
7.77
+0.02 (0.26%)
After-hours: May 12, 2025, 7:44 PM EDT
Zevra Therapeutics Market Cap
Zevra Therapeutics has a market cap or net worth of $423.77 million as of May 12, 2025. Its market cap has increased by 114.02% in one year.
Market Cap
423.77M
Enterprise Value
414.57M
1-Year Change
114.02%
Ranking
Category
Stock Price
$7.75
Market Cap Chart
Since April 16, 2015, Zevra Therapeutics's market cap has increased from $137.80M to $423.77M, an increase of 207.52%. That is a compound annual growth rate of 11.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 425.90M | -4.34% |
| Dec 31, 2024 | 445.20M | 87.69% |
| Dec 29, 2023 | 237.20M | 49.75% |
| Dec 30, 2022 | 158.40M | -48.50% |
| Dec 31, 2021 | 307.60M | 505.51% |
| Dec 31, 2020 | 50.80M | 303.17% |
| Dec 31, 2019 | 12.60M | -73.25% |
| Dec 31, 2018 | 47.10M | -20.71% |
| Dec 29, 2017 | 59.40M | 37.50% |
| Dec 30, 2016 | 43.20M | -84.95% |
| Dec 31, 2015 | 287.00M | 108.27% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 675.26B |
| Johnson & Johnson | 372.03B |
| UnitedHealth Group | 342.63B |
| AbbVie | 337.49B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 230.63B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |